Microbot Medical Inc.
MBOT · Surgical & Medical Instruments & Apparatus · 67.2M shares · +47%/yr ↑ shares · EDGAR filings ↗
Grade
D46Clinical-stage surgical-robotics company — pre-commercial but very well-funded after a raise.
Strengths
- Very strong liquidity — current ratio 23.3 (99th)
Risks
- Pre-commercial, loss-making — ROE -17%, ROA -16%
- Pre-revenue/clinical-stage — history of losses & need for additional capital per risk factors
- Cash burn — FCF -$13M
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Cash burnNegative free cash flow (-13.1M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC
- Notable holderHeld by 4 notable fund(s): GOLDMAN SACHS GROUP INC, STATE STREET CORP, CITADEL ADVISORS LLC +1 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-16.9%
Return on assets
-16.1%
Revenue growth (QoQ)
220.5%
Current ratio
23.3×
Free cash flow
-$13M
EBITDA
-$15M
Tangible book value
$78M
Cash & investments
$79M
Cash runway
24q
Clinical trials
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06141694 ↗ | Assessment of Clin. Capabilities of LIBERTY® Endovascular Robotic System's Performance & Safety in Periph. Vasc. Interv. Peripheral Vascular Interventions | NA | Completed | 2024-10-10 |
Source: ClinicalTrials.gov (U.S. NIH) · active studies first.
Supply chain
Customers (1)
- Emory University Hospital
Suppliers (0)
Named in the 10-K; linked when we track them.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-25 | 2026-06-25 | 0001493152-26-030038 ↗ |
| 8-K | 2026-06-23 | 2026-06-23 | 0001493152-26-029709 ↗ |
| 8-K | 2026-06-16 | 2026-06-16 | 0001493152-26-028824 ↗ |
| 8-K | 2026-06-09 | 2026-06-09 | 0001493152-26-027861 ↗ |
| 8-K | 2026-06-02 | 2026-06-02 | 0001493152-26-026769 ↗ |
| 8-K | 2026-05-26 | 2026-05-26 | 0001493152-26-025171 ↗ |
| 8-K | 2026-05-15 | 2026-05-15 | 0001493152-26-023493 ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | 0001493152-26-022886 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001493152-26-022792 ↗ |
| 8-K | 2026-05-05 | 2026-05-05 | 0001493152-26-021231 ↗ |
| 8-K | 2026-04-30 | 2026-04-30 | 0001493152-26-019775 ↗ |
| 8-K | 2026-04-22 | 2026-04-22 | 0001493152-26-018453 ↗ |